Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Generics get special TGA offer

Posted 23 September 2020

The TGA has launched a new initiative that enables sponsors to request scientific advice on specific data for a fee of $8,570 before applying to register a medicine in Australia.

For the time being the Early Scientific Advice service is open to companies looking to register a generic product and will provide advice on whether a biowaiver is appropriate within 45 working days.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Special Report
Aust Covid Vaccine Tracker
UPDATES: UNICEF stockpiling one billion syringes
Approvals Action
Shakeup for insulin
New biosim plus hypertension and herpes generics
Top of the Hill
Avoiding the Emperor's mistake
Not everyone is convinced about industry's budget win